#ClearsideBio Announces Approval of #XIPERE® #Suprachoroidal Treatment for #Uveitic Macular Edema in #Canada; it's also approved in #USA, #Australia, #Singapore and under regulatory review in #China: ir.clearsidebio.com/news-releases/…  @govcanhealth #OpthoTwitter $CLSD #retinaldisease

#ThrowbackThursday to our study of 130,247 eyes receiving anti-VEGF therapy over 5 years: #DME patients gain only 3.1 letters, wet #AMD patients lose 2.2 letters: "Longer-Term Anti-VEGF Therapy Outcomes in Neovascular AMD, DME & RVO-macular edema..." sciencedirect.com/science/articl…

A mathematical model supporting an association between long-term intraocular pressure increase and episcleral vein pressure increase in thyroid eye disease iovs.arvojournals.org/article.aspx?a…

That's a wrap on #ASRS2025. Mark your calendars for a trip to Canada next summer as the 44th ASRS Annual Meeting comes to beautiful Montreal, July 15-18, 2026. Join us! asrs.org/annual-meeting

91 year old with advanced dry age-related macular degeneration with geographic atrophy. Note significant enlargement of the extramacular atrophy over an 18 month period.

ASGCT, in partnership with the Children's Hospital Association, recently hosted a Congressional briefing addressing equitable access to gene therapies for children with sickle cell disease (#SCD). Read our full summary here: asgct.org/publications/n… #ASGCTAdvocacy

Today, we announced a pivotal program for sura-vec in diabetic retinopathy using suprachoroidal delivery. Learn more: ir.regenxbio.com/news-releases/… $RGNX

Every breakthrough begins long before the clinic. Behind each treatment is years of research, persistence, and public funding. This is what makes vision possible. bit.ly/40EM6si #SeeWhatMatters #VisionResearch #FundFederalVisionResearch

B scan ultrasound showing a rhegmatogenous retinal detachment. Note the posterior hyaloid likely attached to the flap of the retinal break.

Our pub reviews biologic therapies for autoimmune neuro-ophthalmic conditions, #Thyroid eye disease #TED , optic neuritis & #MyastheniaGravis . At Ikarovec, we're extending these immunologic principles to #AMD gene therapy to potentially transform therapy. tandfonline.com/doi/10.1080/14…

Top Poster win at #ASRS2025! 18,000+ GA eyes study shows urgent need for #vision-preserving treatments. Exactly why #ikarovec #genetherapy platform is advancing IKAR-001, our first-in-class therapy for #AMD #GeographicAtrophy. Full paper: journals.lww.com/retinajournal/…

Are you or a loved one seeing a retina specialist soon? Download and print the Preparing for Your Retina Appointment Guide for information on what to expect during your appointment and questions you may want to ask. Access the guide at SeeforaLifetime.org/Resources. #RetinaSpecialist

Our pub explores how IGF-1R targeted therapy revolutionizes #ThyroidEyeDisease treatment. At Ikarovec, we're extending these immunologic principles to #AMD #genetherapy to potentially transform treatment. tandfonline.com/doi/full/10.10…

Our article, coauthored by my favorite #opthalmologist made the of cover of Ophthalmology Management! This #gene-agnostic approach may transform treatment for IRDs by expressing artificial photoreceptors within surviving #retina neurons. #eye

Recently published, reviews the remarkable evolution of #suprachoroidal #drugdelivery. Having helped develop #XIPERE, the 1st FDA-approved suprachoroidal therapy, gratifying to see this catalyze a platform of promising new treatments including #genetherapy tandfonline.com/doi/10.1080/17…

Now is an exciting time to be a retina specialist. A wave of innovations and regulatory approvals has emerged in the past year that has the potential to change our practice patterns. hubs.li/Q03DswHs0

Joe, a lifelong Chicago sports fan, faced vision loss from diabetic macular edema. With care from retina specialists, his vision improved—letting him get back to the games he loves and live life to the fullest. Read more: asrs.org/patients/patie… #RetinaSpecialist #SeeforaLifetime